[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334105-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334105-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","projected-epidemiological-trends-and-burden-of-liver-cancer-by-2040-based-on-gbd-ci5plus-and-who-data","Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data","","Incidence of liver cancer, a leading global cancer, and its mortality burden have been analyzed with projections to 2040 using GLOBOCAN 2020, CI5 volumes I–XI, WHO mortality data, and Global Burden of Disease 2019. Age-standardized incidence and mortality patterns are assessed by gender and age across regions, with emphasis on variations and trends. Results quantify age-standardized rates, average annual percentage change, and future burden, including a projected rise in new cases by 2040 and distinct geographic risk profiles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/projected-epidemiological-trends-and-burden-of-liver-cancer-by-2040-based-on-gbd-ci5plus-and-who-data/334105/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/projected-epidemiological-trends-and-burden-of-liver-cancer-by-2040-based-on-gbd-ci5plus-and-who-data/334105.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data sources were used to project liver cancer trends to 2040?","Question",{"text":63,"@type":64},"Projections rely on age-standardized incidence and mortality rates from GLOBOCAN 2020, CI5 volumes I–XI, the WHO mortality database, and GBD-2019.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do incidence and mortality trends differ by gender and age?",{"text":68,"@type":64},"Findings report notable gender differences, with increases in incidence and mortality reflected in AAPC estimates, and meaningful variation across age groups and regions.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the study project for new liver cancer cases by 2040?",{"text":72,"@type":64},"The projected trend indicates a substantial increase in new liver cancer cases, rising from roughly 905,347 toward an estimated 1,392,474 by 2040.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334105,1790142634,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nProjected epidemiological trendsand burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data  \nQianqian Guo1,9, Xiaorong Zhu2,3,9, Narasimha M. Beeraka4,6,7,8􀀍, Ruiwen Zhao1,2, Siting Li1,2, Fengying Li1,2, Padukudru Anand Mahesh5, Vladimir N. Nikolenko7, Ruitai Fan1,2􀀍 & Junqi Liu1,2􀀍  \nIncidence of liver cancer as one of the most common cancers worldwide and become the significant contributor for the mortality among cancer patients. The disease burden, risk factors, and trends in incidence and mortality of liver cancer globally was described subsequently estimated the projections of liver cancer incidence or mortality by 2040. Data regarding age-standardized incidence and mortality rates for liver cancer was obtained from multiple databases, including GLOBOCAN 2020, CI5 volumes I–XI, WHO mortality database, and Global Burden of Disease (GBD)-2019. Concentrating on worldwide variations, this thorough analysis offers insights into patterns of incidence and mortality based on gender and age. Our findings encompass significant indicators, including age-standardized rates (ASRs), average annual percentage change (AAPC), and future projections extending up to the year  \n2040. Liver cancer holds the sixth position in terms of most frequently diagnosed cancers and stands asthe sixth leading cause of cancer-related deaths worldwide in 2020, accounting for 905,677 new cases and 782,000 fatalities. Additionally, liver cancer contributed to 12,528,421 age-standardized disabilityadjusted life years (DALYs), with an age-standardized DALYs rate of 161.92 in 2019 worldwide. The age-specific incidence rates exhibited significant variations across different regions, showing a fivefold difference in males and females. A significant increase in incidence was observed in North Europe and Asia, while North African countries reported a higher mortality burden (ASR, 10 per 100,000) compared to developed countries. Since last few years, the incidence and mortality rates have increased and attained Annual Average Percentage Change (AAPC) incidence rate of 7.7 (95% CI 3.9–11.6) for men and the highest AAPC mortality rate of 12.2 (95% CI 9.5–15.0) for women. In 2019, Western Europe emerged as the high-risk region for DALYs related to smoking and alcohol consumption, while highincome North America carried a high risk for DALYs associated with a high body-mass index. The projected trend indicates a surge in new liver cancer incident cases, expected to rise from around  \n905,347 to an estimated 1,392,474 by 2040. This study described the evidence pertinent to higher incidence trends in liver cancer, particularly among both young and older adults, encompassing males and females, as well as those who are HIV-infected and HBsAg positive. A significant rise in the young population poses a significant public health concern that warrants attention from healthcare professionals to prioritize the promotion of health awareness and the development of effective cancer prevention strategies, particularly in many developing countries.  \nKeywords Liver cancer, Gender, Age standardized mortality rate, 2040 Projections rates, HDI, WHO database, GBD database, CI5 volumes I–XI  \n1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou 450000, People’s Republic of China. 2Department of Radiation Oncology and Cancer Center, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Erqi District, Zhengzhou 450000, Henan Province, People’s Republic of China. 3Cancer Center, The First Affiliated Hospital of Zhengzhou University, No.  \n1, Jianshe East Road, Zhengzhou 450000, People’s Republic of China. 4Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, Chiyyedu, Andhra Pradesh 515721, India. 5Department of Pulmonary Medicine, JSS Medical College, JSS Academy of Higher Educat","cbCaiuNpJw2nbO1e","https://ap.wps.com/l/cbCaiuNpJw2nbO1e","pdf",7299200,16,"English","# Background and data sources\n## Epidemiological burden and global ranking\n## Risk factors and prior evidence\n# Methods and projection framework\n## Age-standardized rates and AAPC\n## Regional and demographic stratification\n# Findings and 2040 outlook\n## Incidence and mortality trends\n## DALYs and attributable patterns\n# Public health implications\n## Prevention and targeted awareness","[{\"question\":\"What data sources were used to project liver cancer trends to 2040?\",\"answer\":\"Projections rely on age-standardized incidence and mortality rates from GLOBOCAN 2020, CI5 volumes I–XI, the WHO mortality database, and GBD-2019.\"},{\"question\":\"How do incidence and mortality trends differ by gender and age?\",\"answer\":\"Findings report notable gender differences, with increases in incidence and mortality reflected in AAPC estimates, and meaningful variation across age groups and regions.\"},{\"question\":\"What does the study project for new liver cancer cases by 2040?\",\"answer\":\"The projected trend indicates a substantial increase in new liver cancer cases, rising from roughly 905,347 toward an estimated 1,392,474 by 2040.\"}]","Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data | PDF",1790005285]